author_facet Ravina, Bernard
Elm, Jordan
Camicioli, Richard
Como, Peter G.
Marsh, Laura
Jankovic, Joseph
Weintraub, Daniel
Ravina, Bernard
Elm, Jordan
Camicioli, Richard
Como, Peter G.
Marsh, Laura
Jankovic, Joseph
Weintraub, Daniel
author Ravina, Bernard
Elm, Jordan
Camicioli, Richard
Como, Peter G.
Marsh, Laura
Jankovic, Joseph
Weintraub, Daniel
spellingShingle Ravina, Bernard
Elm, Jordan
Camicioli, Richard
Como, Peter G.
Marsh, Laura
Jankovic, Joseph
Weintraub, Daniel
Movement Disorders
The course of depressive symptoms in early Parkinson's disease
Neurology (clinical)
Neurology
author_sort ravina, bernard
spelling Ravina, Bernard Elm, Jordan Camicioli, Richard Como, Peter G. Marsh, Laura Jankovic, Joseph Weintraub, Daniel 0885-3185 1531-8257 Wiley Neurology (clinical) Neurology http://dx.doi.org/10.1002/mds.22572 <jats:title>Abstract</jats:title><jats:p>Little is known about the course of depressive symptoms in Parkinson's disease (PD). We studied the course of clinically significant depressive symptoms using data from two clinical trials that followed 413 early, untreated PD subjects for 12 to 18 months. We measured depressive symptoms with the 15‐item geriatric depression scale (GDS‐15); a score of ≥5 indicates clinically significant depressive symptoms. We used a time‐dependent Cox model to examine the association between demographic variables, PD severity, and medication use on the time to resolution of depressive symptoms. One hundred fourteen of 413 (27.6%) subjects were screened positive for depression during the study, with a median GDS‐15 score of 6, indicating mild symptoms. Within 6 months, 47% of subjects experienced remission of clinically significant depressive symptoms. Subjects with mild depressive symptoms were more likely to develop moderate to severe depressive symptoms (GDS ≥ 10) than those without prior symptoms (relative risk = 6.16). Increasing severity of depressive symptoms, older age, and longer PD duration predicted a lower likelihood of symptom resolution (hazard ratios 0.83–0.92). Mild depressive symptoms have a variable course, with remission and development of more sustained and severe symptoms occurring over time. More severe depressive symptoms may herald a protracted course. © 2009 Movement Disorder Society</jats:p> The course of depressive symptoms in early Parkinson's disease Movement Disorders
doi_str_mv 10.1002/mds.22572
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9tZHMuMjI1NzI
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9tZHMuMjI1NzI
institution DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
imprint Wiley, 2009
imprint_str_mv Wiley, 2009
issn 0885-3185
1531-8257
issn_str_mv 0885-3185
1531-8257
language English
mega_collection Wiley (CrossRef)
match_str ravina2009thecourseofdepressivesymptomsinearlyparkinsonsdisease
publishDateSort 2009
publisher Wiley
recordtype ai
record_format ai
series Movement Disorders
source_id 49
title The course of depressive symptoms in early Parkinson's disease
title_unstemmed The course of depressive symptoms in early Parkinson's disease
title_full The course of depressive symptoms in early Parkinson's disease
title_fullStr The course of depressive symptoms in early Parkinson's disease
title_full_unstemmed The course of depressive symptoms in early Parkinson's disease
title_short The course of depressive symptoms in early Parkinson's disease
title_sort the course of depressive symptoms in early parkinson's disease
topic Neurology (clinical)
Neurology
url http://dx.doi.org/10.1002/mds.22572
publishDate 2009
physical 1306-1311
description <jats:title>Abstract</jats:title><jats:p>Little is known about the course of depressive symptoms in Parkinson's disease (PD). We studied the course of clinically significant depressive symptoms using data from two clinical trials that followed 413 early, untreated PD subjects for 12 to 18 months. We measured depressive symptoms with the 15‐item geriatric depression scale (GDS‐15); a score of ≥5 indicates clinically significant depressive symptoms. We used a time‐dependent Cox model to examine the association between demographic variables, PD severity, and medication use on the time to resolution of depressive symptoms. One hundred fourteen of 413 (27.6%) subjects were screened positive for depression during the study, with a median GDS‐15 score of 6, indicating mild symptoms. Within 6 months, 47% of subjects experienced remission of clinically significant depressive symptoms. Subjects with mild depressive symptoms were more likely to develop moderate to severe depressive symptoms (GDS ≥ 10) than those without prior symptoms (relative risk = 6.16). Increasing severity of depressive symptoms, older age, and longer PD duration predicted a lower likelihood of symptom resolution (hazard ratios 0.83–0.92). Mild depressive symptoms have a variable course, with remission and development of more sustained and severe symptoms occurring over time. More severe depressive symptoms may herald a protracted course. © 2009 Movement Disorder Society</jats:p>
container_issue 9
container_start_page 1306
container_title Movement Disorders
container_volume 24
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792338330967343115
geogr_code not assigned
last_indexed 2024-03-01T15:30:17.154Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+course+of+depressive+symptoms+in+early+Parkinson%27s+disease&rft.date=2009-07-15&genre=article&issn=1531-8257&volume=24&issue=9&spage=1306&epage=1311&pages=1306-1311&jtitle=Movement+Disorders&atitle=The+course+of+depressive+symptoms+in+early+Parkinson%27s+disease&aulast=Weintraub&aufirst=Daniel&rft_id=info%3Adoi%2F10.1002%2Fmds.22572&rft.language%5B0%5D=eng
SOLR
_version_ 1792338330967343115
author Ravina, Bernard, Elm, Jordan, Camicioli, Richard, Como, Peter G., Marsh, Laura, Jankovic, Joseph, Weintraub, Daniel
author_facet Ravina, Bernard, Elm, Jordan, Camicioli, Richard, Como, Peter G., Marsh, Laura, Jankovic, Joseph, Weintraub, Daniel, Ravina, Bernard, Elm, Jordan, Camicioli, Richard, Como, Peter G., Marsh, Laura, Jankovic, Joseph, Weintraub, Daniel
author_sort ravina, bernard
container_issue 9
container_start_page 1306
container_title Movement Disorders
container_volume 24
description <jats:title>Abstract</jats:title><jats:p>Little is known about the course of depressive symptoms in Parkinson's disease (PD). We studied the course of clinically significant depressive symptoms using data from two clinical trials that followed 413 early, untreated PD subjects for 12 to 18 months. We measured depressive symptoms with the 15‐item geriatric depression scale (GDS‐15); a score of ≥5 indicates clinically significant depressive symptoms. We used a time‐dependent Cox model to examine the association between demographic variables, PD severity, and medication use on the time to resolution of depressive symptoms. One hundred fourteen of 413 (27.6%) subjects were screened positive for depression during the study, with a median GDS‐15 score of 6, indicating mild symptoms. Within 6 months, 47% of subjects experienced remission of clinically significant depressive symptoms. Subjects with mild depressive symptoms were more likely to develop moderate to severe depressive symptoms (GDS ≥ 10) than those without prior symptoms (relative risk = 6.16). Increasing severity of depressive symptoms, older age, and longer PD duration predicted a lower likelihood of symptom resolution (hazard ratios 0.83–0.92). Mild depressive symptoms have a variable course, with remission and development of more sustained and severe symptoms occurring over time. More severe depressive symptoms may herald a protracted course. © 2009 Movement Disorder Society</jats:p>
doi_str_mv 10.1002/mds.22572
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9tZHMuMjI1NzI
imprint Wiley, 2009
imprint_str_mv Wiley, 2009
institution DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1
issn 0885-3185, 1531-8257
issn_str_mv 0885-3185, 1531-8257
language English
last_indexed 2024-03-01T15:30:17.154Z
match_str ravina2009thecourseofdepressivesymptomsinearlyparkinsonsdisease
mega_collection Wiley (CrossRef)
physical 1306-1311
publishDate 2009
publishDateSort 2009
publisher Wiley
record_format ai
recordtype ai
series Movement Disorders
source_id 49
spelling Ravina, Bernard Elm, Jordan Camicioli, Richard Como, Peter G. Marsh, Laura Jankovic, Joseph Weintraub, Daniel 0885-3185 1531-8257 Wiley Neurology (clinical) Neurology http://dx.doi.org/10.1002/mds.22572 <jats:title>Abstract</jats:title><jats:p>Little is known about the course of depressive symptoms in Parkinson's disease (PD). We studied the course of clinically significant depressive symptoms using data from two clinical trials that followed 413 early, untreated PD subjects for 12 to 18 months. We measured depressive symptoms with the 15‐item geriatric depression scale (GDS‐15); a score of ≥5 indicates clinically significant depressive symptoms. We used a time‐dependent Cox model to examine the association between demographic variables, PD severity, and medication use on the time to resolution of depressive symptoms. One hundred fourteen of 413 (27.6%) subjects were screened positive for depression during the study, with a median GDS‐15 score of 6, indicating mild symptoms. Within 6 months, 47% of subjects experienced remission of clinically significant depressive symptoms. Subjects with mild depressive symptoms were more likely to develop moderate to severe depressive symptoms (GDS ≥ 10) than those without prior symptoms (relative risk = 6.16). Increasing severity of depressive symptoms, older age, and longer PD duration predicted a lower likelihood of symptom resolution (hazard ratios 0.83–0.92). Mild depressive symptoms have a variable course, with remission and development of more sustained and severe symptoms occurring over time. More severe depressive symptoms may herald a protracted course. © 2009 Movement Disorder Society</jats:p> The course of depressive symptoms in early Parkinson's disease Movement Disorders
spellingShingle Ravina, Bernard, Elm, Jordan, Camicioli, Richard, Como, Peter G., Marsh, Laura, Jankovic, Joseph, Weintraub, Daniel, Movement Disorders, The course of depressive symptoms in early Parkinson's disease, Neurology (clinical), Neurology
title The course of depressive symptoms in early Parkinson's disease
title_full The course of depressive symptoms in early Parkinson's disease
title_fullStr The course of depressive symptoms in early Parkinson's disease
title_full_unstemmed The course of depressive symptoms in early Parkinson's disease
title_short The course of depressive symptoms in early Parkinson's disease
title_sort the course of depressive symptoms in early parkinson's disease
title_unstemmed The course of depressive symptoms in early Parkinson's disease
topic Neurology (clinical), Neurology
url http://dx.doi.org/10.1002/mds.22572